mesoestetic Pharma Group
Ramón Farré Montesó has a diverse work experience spanning several industries. Ramón is currently working as the National Head of Direct Sales at mesoestetic Pharma Group, where they lead the development and marketing of top-quality products in the field of aesthetic medicine. Prior to this, they served as the Head of Sales at Crusat S.A., a leading food service and FMCG distribution company, where they were responsible for strategic sales planning and implementation, as well as the management and development of the sales team. Before that, Ramón worked as a Regional Sales Manager at CIN VALENTINE, S.A.U., overseeing the decorative division in the Cataluña, Levante, Baleares, and Aragón regions. Ramón also gained valuable experience at L'Oréal, where they held various roles, including Key Account Executive and Sales Executive, in the Active Cosmetics Division. Additionally, Ramón has worked in business development at CIN VALENTINE, S.A.U., and as a Sales and Marketing Assistant at BASF.
Ramón Farré Montesó pursued their education with a focus on business administration and management. From 2007 to 2012, they attended the Universitat de Barcelona, where they obtained a degree in Business Administration and Management with a specialization in Marketing and Sales. Continuing their academic journey, Ramón furthered their knowledge by enrolling at the IESE Business School from 2019 to 2021. During this period, they pursued an Executive MBA, specializing in Business Administration and Management, General.
This person is not in any offices
mesoestetic Pharma Group
mesoestetic Pharma Group is a pharmaceutical laboratory internationally recognized as one of the leaders in the field of dermatology and aesthetic medicine offering innovative and efficient solutions for skin treatment and care. The company manufactures cosmeceutical, nutraceuticals, class III intradermal administration medical devices with CE conformity marking, topical drugs as well as energy based medical aesthetic devices. This full range of integral aesthetic solutions is characterized by a high degree of innovation and significant scientific contribution. Since its inception in 1984, the firm has been committed to meeting strict pharmaceutical standards and complying with the most stringent European regulations. The company facilities are authorized by the Spanish Agency for Medicines and Medical Devices (AEMYPS) and include three pharmaceutical manufacturing lines (cosmeceuticals and nutraceuticals / intradermal administration medical devices / injectable and topical drugs), as well as a Biotechnology Unit and a Monitoring and Follow-Up Unit. These units enable the company to cover the entire production cycle and carry out in vitro and in vivo studies to ensure the safety and efficacy of its products.